新股暗盤 | 喆麗控股(2209.HK)暗盤段暴漲逾40%
格隆匯7月8日丨據富途證券,喆麗控股(2209.HK)暗盤段現報4.72港元,較發行價3.28港元漲43.9%。公司是一間網上零售商,主要從事採購及銷售第三方時裝、美容、娛樂產品。2018年至2020年收益分別為8536.4萬、1.17億、1.73億美元,溢利分別為399.2萬、336.9萬、1122萬美元,每股有形資產淨值0.736-0.767港元,2020歷史市盈率13.61-15.10倍。此次上市,全球發售3954萬股,其中香港發售1977萬股,國際發售1977萬股,每手1000股,香港公開發售獲145.3倍認購,淨籌9100萬港元,當中約54%擬用於加強集團市場營銷工作,以吸納及保留客户。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.